Correction to Oplustilova L, et al. Cell Cycle Volume 11, Issue 20; pp. 3837–50

It has come to the attention of the authors that in their Report, “Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment,” in the October 15, 2012 issue of Cell Cycle, an important source of funding was omitted. Dr M. Mistrik was supported by the GACR grant no. 301/11/P554.

Oplustilova L, Wolanin K, Mistrik M, Korinkova G, Simkova D, Bouchal J, Lenobel R, Bartkova J, Lau A, O'Connor MJ, Lukas J, Bartek J. Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment. Cell Cycle. 2012;11:3837–50. doi: 10.4161/cc.22026.